Position in SRRK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,476,485
+$12,756,586 QoQ
Shares Held
245,027
+1573.2% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#60
of 304 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. SRRK ranks #66 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in SRRK
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,476,485 | 245,027 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $719,899 | 14,644 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $613,836 | 13,935 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $688,567 | 18,490 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,827,143 | 136,283 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $10,212,286 | 317,645 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $28,822,769 | 666,885 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,568,149 | 195,774 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,116,144 | 254,039 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,986,740 | 111,866 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,791,470 | 95,291 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $488,636 | 68,822 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $450,198 | 59,708 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $409,744 | 51,218 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $794,001 | 87,735 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $676,943 | 97,683 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $187,911 | 34,228 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||